Aclaris Therapeutics (ACRS) Reports In-Line Q4 EPS, Revenues Beat

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 9/21/2026

1. SPY
2. XENE
3. NUE
4. HUBS
5. ONON
6. FFAI
7. BA
8. RTB
9. ACN
10. AAPL

Go back to Aclaris Therapeutics (ACRS) Reports In-Line Q4 EPS, Revenues Beat
(NASDAQ: ACRS) Delayed: 5.50 --0 (-0%)
Previous Close $5.50    52 Week High $33.88 
Open $5.50    52 Week Low $14.12 
Day High $5.50    P/E N/A 
Day Low $5.50    EPS $0.00 
Volume 67